BIJAN SAFAI, MD
Dermatology at Park Ave, New York, NY
License number
New York 113002
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
625 Park Ave, New York, NY 10021
Phone
(212) 988-8918
(212) 744-6108 (Fax)
(212) 744-6108 (Fax)
Personal information
See more information about BIJAN SAFAI at radaris.comName
Address
Phone
340 E 64Th St APT 14K, New York, NY 10065
New York, NY
336 64Th St, New York, NY 10021
340 E 64Th St #4F, New York, NY 10065
340 64Th St, New York, NY 10043
Professional information
Dr. Bijan Safai, New York NY - MD (Doctor of Medicine)
Specialties:
Dermatology
Address:
Metropolitan Hospital DER Res Prgm
1901 1St Ave SUITE 14B, New York 10029
(212) 423-6511 (Phone)
Bijan Safai MD
625 Park Ave, New York 10065
(212) 988-8918 (Phone)
1901 1St Ave SUITE 14B, New York 10029
(212) 423-6511 (Phone)
Bijan Safai MD
625 Park Ave, New York 10065
(212) 988-8918 (Phone)
Certifications:
Dermatology, 1974
Awards:
Healthgrades Honor Roll
Languages:
English, Farsi
Hospitals:
Metropolitan Hospital DER Res Prgm
1901 1St Ave SUITE 14B, New York 10029
Bijan Safai MD
625 Park Ave, New York 10065
Metropolitan Hospital Center
1901 1St Ave, New York 10029
1901 1St Ave SUITE 14B, New York 10029
Bijan Safai MD
625 Park Ave, New York 10065
Metropolitan Hospital Center
1901 1St Ave, New York 10029
Education:
Medical School
Tehran University Of Medical Sciences, Faculty Of Medicine
Graduated: 1965
Nassau County Med Center
Graduated: 1969
New York University Med Center
Graduated: 1973
Nyu Med Center Va Hospital
Graduated: 1970
Sloan Kettering Cancer Center
Graduated: 1974
Tehran University Of Medical Sciences, Faculty Of Medicine
Graduated: 1965
Nassau County Med Center
Graduated: 1969
New York University Med Center
Graduated: 1973
Nyu Med Center Va Hospital
Graduated: 1970
Sloan Kettering Cancer Center
Graduated: 1974
Bijan DR Safai, Bronx NY
Specialties:
Dermatology, Internal Medicine, Clinical & Laboratory Immunology
Work:
Montefiore North Ambulatory Care
4234 Bronx Blvd, Bronx, NY 10466 Dermatology And Medical Research
625 Park Ave, New York, NY 10065 Metropolitan Hospital Center
1901 1St Ave, New York, NY 10029
4234 Bronx Blvd, Bronx, NY 10466 Dermatology And Medical Research
625 Park Ave, New York, NY 10065 Metropolitan Hospital Center
1901 1St Ave, New York, NY 10029
Education:
Tehran School Of Medical Sciences (1965)
Monoclonal Antibodies To Skin Cells
US Patent:
4649115, Mar 10, 1987
Filed:
Mar 31, 1983
Appl. No.:
6/480717
Inventors:
Bijan Safai - New York NY
Edward A. Boyse - New York NY
Edward A. Boyse - New York NY
Assignee:
Sloan-Kettering Institute - New York NY
International Classification:
G01N 3354, C12N 500, C12N 1500, C12R 191
US Classification:
435240
Abstract:
Successive layers of guinea pig epidermis display discrete antigenic markers that are recognized by a selected panel of five monoclonal antibodies produced by hybridomas resulting from immunization of mice with suspensions of dissociated viable guinea pig epidermal cells. Antigen to Gpsk-1 marks the basement membrane, which membrane is probably produced by basal cells. Antigen to Gpsk-2 is expressed by basal and suprabasal cells. Antigens to both Gpsk-3 and Gpsk-4 occur on the spinous and overlying layers but are distinguished by differences in their representation on certain non-epidermal cell types and on other epithelia. Antigen to Gpsk-5 is found on basement membrane and on spinous and overlying granular and horny cells. Antigens to Gpsk-2 through 5 are situated at the cell surface and may recognize integral plasma membrane molecules expressed in differentiative sequence. The five antibodies differ also in their antigenic marker distribution among epithelial as well as other selected tissue types.
Head Lice Medication And Treatment
US Patent:
2004019, Sep 30, 2004
Filed:
Mar 24, 2003
Appl. No.:
10/395807
Inventors:
Bijan Safai - New York NY, US
International Classification:
A01N025/00
US Classification:
424/405000
Abstract:
The medication for head lice includes glue and a de-licing insecticide such as d-Limonene or highly concentrated lemon juice. The glue is effective because application of the glue, in a soft or liquid state, to the hair and scalp results in the lice becoming entrapped in the glue. When the glue dries, the lice entrapped in it become fully immobilized. Immobilization of lice for a period of time will cause the lice to die. The medication is applied to the hair and scalp of a human containing head lice to effectively kill the head lice without having any known harmful effects on the human. Both the glue and de-licing insecticide are water soluble to facilitate removal of the medication from the hair and scalp. The treatment for head lice includes application of the glue and de-licing insecticide, without necessarily being in combination with the other, to the hair and scalp to kill the lice.
Head Lice Medication And Treatment
US Patent:
2006017, Aug 10, 2006
Filed:
Mar 15, 2006
Appl. No.:
11/376041
Inventors:
Bijan Safai - New York NY, US
International Classification:
A01N 43/04, A01N 25/00
US Classification:
424405000, 514054000
Abstract:
The medication for head lice includes glue and a de-licing insecticide such as d-Limonene or highly concentrated lemon juice. The glue is effective because application of the glue, in a soft or liquid state, to the hair and scalp results in the lice becoming entrapped in the glue. When the glue dries, the lice entrapped in it become fully immobilized. Immobilization of lice for a period of time will cause the lice to die. The medication is applied to the hair and scalp of a human containing head lice to effectively kill the head lice without having any known harmful effects on the human. Both the glue and de-licing insecticide are water soluble to facilitate removal of the medication from the hair and scalp. The treatment for head lice includes application of the glue and de-licing insecticide, without necessarily being in combination with the other, to the hair and scalp to kill the lice.